Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: an in vitro study

Eur Respir J. 2002 Aug;20(2):332-8. doi: 10.1183/09031936.02.00282002.

Abstract

Patients with chronic obstructive pulmonary disease (COPD) show impaired hypoxic pulmonary vasoconstriction that might contribute to abnormal gas exchange and could be related to endothelial dysfunction in pulmonary arteries. The aim of the study was to investigate the response of PA to hypoxic stimulus in vitro in COPD, and the role of endothelium-derived nitric oxide (NO) in this response. The pulmonary arteries of 25 patients who underwent lung resection were studied. Patients were divided into controls, COPD+normoxaemia (COPDN) and COPD+ hypoxaemia (COPDH). Hypoxic vasoconstriction (HV) was evaluated before and after stimulation or inhibition of the endothelial release of NO, and in the presence of exogenous NO. Compared with the other groups, HV was reduced in COPDH. The magnitude of HV correlated with the oxygen tension in arterial blood. The hypoxic stimulus induced greater contraction after stimulating endothelial release of NO, whereas its inhibition practically abolished HV. Exogenous NO completely inhibited HV. Maximal relaxation induced by endothelium-dependent vasodilators correlated with the magnitude of HV. In conclusion, pulmonary arteries of patients with chronic obstructive pulmonary disease and hypoxaemia have an impaired response to hypoxic stimulus, and the endothelial release of nitric oxide modulates hypoxic vasoconstriction. The depressed response of pulmonary arteries to hypoxia may contribute to abnormal gas exchange in chronic obstructive pulmonary disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Bronchodilator Agents / analysis*
  • Bronchodilator Agents / pharmacology*
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiopathology
  • Female
  • Hemodynamics / drug effects
  • Hemodynamics / physiology
  • Humans
  • Hypoxia / physiopathology*
  • In Vitro Techniques
  • Male
  • Middle Aged
  • Nitric Oxide / analysis*
  • Nitric Oxide / pharmacology*
  • Pulmonary Artery / drug effects*
  • Pulmonary Artery / physiopathology*
  • Pulmonary Disease, Chronic Obstructive / physiopathology*
  • Reaction Time / drug effects
  • Reaction Time / physiology
  • Time Factors
  • Vasoconstriction / drug effects*
  • Vasoconstriction / physiology*

Substances

  • Bronchodilator Agents
  • Nitric Oxide